Cyclin Dependent Kinase Inhibitor 1A Interacting Zinc Finger Protein 1 (CDKN1A Interacting Zinc Finger Protein 1, CIZ1, LSFR1, ZNF356)

437 EUR

50ug

GEN600142

N/A

N/A

N/A

N/A

N/A

8C96

IgG1

Antibodies

Monoclonal

Western Blot (WB)

Mouse (Mus musculus)

Mnoclonal antibodies

Human (Homo sapiens)

Affinity Purified by Protein G affinity chromatography.

Cyclin Dependent Kinase Inhibitor 1A Interacting Zinc Finger Protein 1

Supplied as a sterile-filtered liquid in PBS, pH 7.4, 1% BSA, 0.05% sodium azide.

N/A; Due to limited knowledge and inability for testing each and every species, the reactivity of the antibody may extend to other species which are not listed hereby.

Recognizes human Cyclin Dependent Kinase Inhibitor 1A Interacting Zinc Finger Protein 1.; Since it is not possible to test each and every species our knowledge on the corss reactivity of the antibodies is limited. This particular antibody might cross react with speacies outside of the listed ones.

Store the antibody at +4 degrees Celsius for short term storage.. For long-term storage and to avoid repeated freezing and thawing, add sterile 40-50% glycerol, aliquot and For optimal long term storage, the antibody should be kept at -20 degrees Celsius. Aliquots are stable for at least 12 months the antibody should be stored at -20 degrees Celsius.. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Finger like and finger proteins are like zinc fingers small proteins with a structural motif that is characterized by the coordination of one or more zinc ions in order to stabilize the fold. Homeobox and homeodomain families.Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.